Aminobenzoic acids and derivatives
Aobchem 2-Bromo-5-nitrobenzamide | ≥97% | CAS 41052-26-0 | C7H5BrN2O3 | 1g
2-Bromo-5-nitrobenzamide | ≥97% | CAS 41052-26-0 | C7H5BrN2O3 | 1g
Aobchem 3-Iodo-2-methylbenzamide | 95% | CAS 52107-88-7 | C8H8INO | 250mg
3-Iodo-2-methylbenzamide | 95% | CAS 52107-88-7 | C8H8INO | 250mg
Aobchem 2 6-Dichloro-3-methylbenzamide | 97% | CAS 1803835-81-5 | C8H7Cl2NO | 500mg
2 6-Dichloro-3-methylbenzamide | 97% | CAS 1803835-81-5 | C8H7Cl2NO | 500mg
Aobchem N-isopropyl-3-methylbenzamide | 95% | CAS 6958-48-1 | C11H15NO | 500mg
N-isopropyl-3-methylbenzamide | 95% | CAS 6958-48-1 | C11H15NO | 500mg
Aobchem N-isopropyl-3-methylbenzamide | 95% | CAS 6958-48-1 | C11H15NO | 250mg
N-isopropyl-3-methylbenzamide | 95% | CAS 6958-48-1 | C11H15NO | 250mg
Medchemexpress LLC 4-methylbenzamide oxime | 19227-13-5 | MFCD00019952 | 99.2% | 150.18 g/mol | C8H10N2O | 1 G
4-Methylbenzamide oxime is a small-molecule biochemical reagent used as a model benzamide oxime and as a substrate for mitochondrial amidoxime reducing component (mARC) enzyme assays. It is supplied as a high-purity solid for laboratory use.
- High purity suitable for biochemical assays.
- Functions as a substrate for mARC catalytic enzyme reduction.
- Molecular formula C8H10N2O and molecular weight 150.18 g/mol.
- Available in common laboratory pack sizes for small-scale experiments.
Medchemexpress LLC Pamufetinib mesylate | 1688673-09-7 | 99.2% | 614.66 | C28H27FN4O7S2 | 25MG
Pamufetinib mesylate is a research-stage small-molecule kinase inhibitor that targets vascular endothelial growth factor receptors (VEGFR) and hepatocyte growth factor receptor (c-Met/HGFR). It exhibits low-nanomolar inhibition of recombinant VEGFR2 and MET and is used in preclinical studies of angiogenesis and MET-driven signaling in oncology research. The compound is provided as the mesylate salt for laboratory use and should be stored under controlled conditions to maintain stability.
- Provides low-nanomolar inhibition of VEGFR2 and MET (IC50 ≈ 30-32 nM).
- Suitable for preclinical studies of angiogenesis and MET-dependent signaling.
- High chemical purity as confirmed by batch analysis (~99.2%).
- Mesylate salt form for convenient laboratory handling.
- Stable when stored under recommended conditions to preserve activity.
Medchemexpress LLC Pergolide (mesylate) | 66104-23-2 | HY-13720A | 100.0% | 410.59 | 10 MG
Pergolide mesylate (Pergolide methanesulfonate) is an Ergoline derivative that acts as a potent and orally active agonist for dopamine D1 and D2 receptors. It can be used for Parkinson's disease and hyperprolactinaemia research.
- Acts as a potent and orally active agonist for dopamine D1 and D2 receptors.
- Used in research for Parkinson's disease.
- Used in research for hyperprolactinaemia.
- Inhibits H2O2-induced cell death in SH-SY5Y neuroblastoma cells.
- Protects SH-SY5Y neuroblastoma cells from cell death.
- Reduces working/reference memory errors in a rat model of Parkinson's disease.
- Facilitates spatial memory.
- Improves brain oxidative balance.
Medchemexpress LLC SNS-314 mesylate | 1146618-41-8 | >98.0% | 50 MG
SNS-314 mesylate is a potent pan-Aurora kinase inhibitor for preclinical research that inhibits Aurora A, B, and C at low nanomolar concentrations.
- Potent inhibition of Aurora A, B, and C (IC50: Aurora A 9 nM; Aurora B 31 nM; Aurora C 6 nM).
- Supplied as the mesylate salt for improved handling and stability.
- Molecular formula C18H15ClN6OS2 · CH4O3S, molecular weight 527.04 g·mol-1.
- High purity, typically >98.0% by HPLC.
- Intended for in vitro research applications in cell cycle and oncology studies.
Medchemexpress LLC CEP-28122 mesylate salt | 2070009-30-0 | 99.9% | 635.17 | 50 MG
CEP-28122 mesylate salt | 2070009-30-0 | 99.9% | 635.17 | 50 MG
Apexbio Technology LLC Safinamide Mesylate 202825-46-5 500mg
Safinamide Mesylate (CAS 202825-46-5) is the mesylate salt form of safinamide a selective and reversible inhibitor of monoamine oxidase B (MAO-B) Safinamide exhibits an IC50 of 98 nM for MAO-B inhibition leading to enhanced dopaminergic transmission by reducing dopamine degradation In addition to MAO-B inhibition safinamide modulates sodium and calcium channels (IC50 8 2 M and 31 5 M respectively) and suppresses glutamate release ( 56 4 M) contributing to its anticonvulsant properties Research applications include the study of Parkinson s disease mechanisms and the investigation of dopaminergic and glutamatergic modulation
Medchemexpress LLC Saquinavir mesylate | 149845-06-7 | 99.8% | 766.95 | 50 MG
Saquinavir mesylate is an orally active HIV protease inhibitor that can be used in the research of AIDS. It also has anti-inflammatory activity and can induce apoptosis of human red blood cells.
- Orally active HIV protease inhibitor.
- Can be used in the research of AIDS.
- Has anti-inflammatory activity.
- Can induce apoptosis of human red blood cells.
Medchemexpress LLC Purinostat mesylate | 2650188-32-0 | 99.5% | 586.62 | 25 MG
Purinostat mesylate is a selective inhibitor of HDAC. It inhibits class I and class IIb HDACs with IC50s ranging from 0.81 to 11.5 nM. It induces apoptosis and affects the cell cycle of LAMA84 and 188 BL-2 cells, showing potent anti-leukemia effects in vivo. It is used for research on lymphoblastic leukemia.
- Inhibits class I and class IIb HDACs
- Induces apoptosis and affects cell cycle of LAMA84 and 188 BL-2 cells
- Suppresses leukemia progression in vivo
- Demonstrates potent anti-leukemia effects in BCR-ABL(T315I)-induced primary B-ALL mice
Cayman Chemical WIN 55 212 mesylate
A racemic mixture of (+)-WIN 55,212-2 and (−)-WIN 55,212-3; inhibits electrically induced contractions in mouse vas deferens preparations (IC50 = 0.006 µM) and reduces PG synthesis by 35% in mouse brain microsomes at 30 µM; decreases acetylcholine-induced writhing in mice (ED50 = 0.25 mg/kg); induces hypolocomotion, analgesia, hypothermia, and catalepsy in mice (ED50s = 1.09, 0.5, 3.01 and 6.8 mg/kg, respectively)